# MSC Secretome and rTMS for Motor Recovery After Subacute Ischemic Stroke

Study · id `cardio:ct-nct07874269` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07874269](<https://clinicaltrials.gov/study/NCT07874269>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07874269

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 205 participants.

## Technical summary

Registry record NCT07874269. Randomized; double masking; primary purpose treatment. Start 2026-11 (anticipated); primary completion 2027-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 205 participants (planned count; ClinicalTrials.gov record NCT07874269, source copy `cardio:ctgov-nct07874269-2026-10-21`, retrieved 2026-10-26)
- Planned start: 2026-11 (anticipated) (ClinicalTrials.gov record NCT07874269, source copy `cardio:ctgov-nct07874269-2026-10-21`, retrieved 2026-10-26)
- Primary completion: 2027-07 (anticipated) (ClinicalTrials.gov record NCT07874269, source copy `cardio:ctgov-nct07874269-2026-10-21`, retrieved 2026-10-26)
- Completion: 2027-07 (anticipated) (ClinicalTrials.gov record NCT07874269, source copy `cardio:ctgov-nct07874269-2026-10-21`, retrieved 2026-10-26)
- Countries: Indonesia (ClinicalTrials.gov record NCT07874269, source copy `cardio:ctgov-nct07874269-2026-10-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07874269-2026-10-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: MSC Secretome and rTMS for Motor Recovery After Subacute Ischemic Stroke
- Condition: Ischemic Stroke
- Intervention (Biological): Mesenchymal Stem Cell-Derived Secretome
- Intervention (Device): Active Repetitive Transcranial Magnetic Stimulation
- Intervention (Drug): 0.9% Sodium Chloride Placebo
- Intervention (Device): Sham Repetitive Transcranial Magnetic Stimulation
- Lead sponsor: Jumraini Tammasse
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: ccd4268999baee35938b2aa62e8a255171526302803a38571cc4d6d8c79a332e
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
